Percutaneous transluminal angioplasty of hepatic artery stenosis in patients after orthotopic liver transplantation: mid-term results

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F11%3A00002538" target="_blank" >RIV/00023001:_____/11:00002538 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1007/s00270-010-0082-x" target="_blank" >http://dx.doi.org/10.1007/s00270-010-0082-x</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00270-010-0082-x" target="_blank" >10.1007/s00270-010-0082-x</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Percutaneous transluminal angioplasty of hepatic artery stenosis in patients after orthotopic liver transplantation: mid-term results

Popis výsledku v původním jazyce

This study was designed to present our experience with percutaneous treatment of hepatic artery stenosis in orthotopic liver transplant patients and to evaluate the efficacy, technical outcomes, and mid-term clinical results of the procedure. Twenty-twopercutaneous transluminal angioplasties (PTAs) were performed in 19 liver transplant recipients at our institution between 1998 and 2010. Stents were placed into the hepatic/celiac artery in 16 PTAs, but balloon dilatation alone was performed in 6 because of the anatomical condition of the vessel. PTA/stenting was indicated in 17 patients because of elevated liver enzymes; 2 patients were asymptomatic. The objective of treating stenosis was prevention of long-term complications, including thrombosis. Technical success was achieved in all patients. There was only one complication: dissection of the treated artery without any subsequent adverse effects. In all patients, elevated liver enzyme levels improved after treatment. No restenosis

Název v anglickém jazyce

Percutaneous transluminal angioplasty of hepatic artery stenosis in patients after orthotopic liver transplantation: mid-term results

Popis výsledku anglicky

This study was designed to present our experience with percutaneous treatment of hepatic artery stenosis in orthotopic liver transplant patients and to evaluate the efficacy, technical outcomes, and mid-term clinical results of the procedure. Twenty-twopercutaneous transluminal angioplasties (PTAs) were performed in 19 liver transplant recipients at our institution between 1998 and 2010. Stents were placed into the hepatic/celiac artery in 16 PTAs, but balloon dilatation alone was performed in 6 because of the anatomical condition of the vessel. PTA/stenting was indicated in 17 patients because of elevated liver enzymes; 2 patients were asymptomatic. The objective of treating stenosis was prevention of long-term complications, including thrombosis. Technical success was achieved in all patients. There was only one complication: dissection of the treated artery without any subsequent adverse effects. In all patients, elevated liver enzyme levels improved after treatment. No restenosis

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FJ - Chirurgie včetně transplantologie

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cardiovascular and Interventional Radiology

ISSN

0174-1551

e-ISSN

—

Svazek periodika

34

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

DE - Spolková republika Německo

Počet stran výsledku

7

Strana od-do

1165-1171

Kód UT WoS článku

000297724600005

EID výsledku v databázi Scopus

—